Laron Syndrome, also known as growth hormone insensitivity syndrome, is related to growth hormone deficiency and isolated growth hormone deficiency. An important gene associated with Laron Syndrome is GHR (Growth Hormone Receptor), and among its related pathways/superpathways are ERK Signaling and GPCR Pathway. The drugs Mecasermin and Insulin have been mentioned in the context of this disorder. Affiliated tissues include pituitary and bone, and related phenotypes are delayed skeletal maturation and abnormal facial shape